reports
- Jonathan Moreland
THOR Industries Announces Re-Authorization of $400 Million Share Buyba...
THOR Industries Announces Re-Authorization of $400 Million Share Buyback ELKHART, Ind., June 23, 2025 (GLOBE NEWSWIRE) -- THOR Industries, Inc. (NYSE: THO) today announced that its Board of Directors has retired the Company’s existing share repurchase authorization which was set to expire on July 31, 2025 and re-authorized the Company to repurchase up to $400 million of its Common Stock. The Company may purchase shares on a discretionary basis from time to time through open market purchases, privately negotiated transactions or other means. The timing and amount of any transactions will ...
Savara Inc: 1 director
A director at Savara Inc bought 48,225 shares at 2.044USD and the significance rating of the trade was 63/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
- Jonathan Moreland
VAC MARRIOTT VACATIONS WORLDWIDE CORPORATION
HPP HUDSON PACIFIC PROPERTIES INC.
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
MOD MODINE MANUFACTURING COMPANY
GLP GLOBAL PARTNERS LP
CDXS CODEXIS
BUSE FIRST BUSEY CORPORATION
AMPH AMPHASTAR PHARMACEUTICALS INC
PZG PARAMOUNT GOLD NEVADA CORP.
GIII G-III APPAREL GROUP LTD.
OXM OXFORD INDUSTRIES INC.
CIA CITIZENS INC. CL A
FLL FULL HOUSE RESORTS INC.
ALOT
MLP ASTRONOVA INC.
BCBP MAUI LAND & PINEAPPLE CO. INC.
BRT BCB BANCORP INC.
STKL BRT APARTMENTS
RSSS SUNOPTA
BWB INC.
BHC RESEARCH SOLUTIONS
SONO BRIDGEWATER BANCSHARES
AMPY BAUSCH HEALTH COMPANIES INC.
ENX SONOS
WSC AMPLIFY ENERGY
DLHC EATON VANCE NEW YORK MUNICIPAL BOND FUND
GRNT WILLSCOT MOBILE MINI HOLDINGS CORP
NUVB DALEIGH HOLDINGS CORP
XLO GRANIT SKOPKE
NVCT NUVATION BIO INC (A)
TCBX XILIO THERAPEUTICS INC
BARK NUVECTIS PHARMA INC
OPAL THIRD COAST BANCSHARES INC
GTE ORIGINAL BARK CO
SRM OPAL FUELS INC
MNR GRAN TIERRA ENERGY INC.
SDHC SRM ENTERTAINMENT INC
NCDL MACH NATURAL RESOURCES LP
SUNS SMITH DOUGLAS HOMES CORP
EVM NUVEEN CHURCHILL DIRECT LENDING CORP
LION SUNRISE REALTY TRUST
HYMC EATON VANCE INSD CALIF MUN BD FD
LIONSGATE STUDIOS CORP
HYCROFT MINING HOLDING CORPORATION
Moleculin Announces $5.9 Million Public Offering
Moleculin Announces $5.9 Million Public Offering HOUSTON, June 20, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced the pricing of a public offering consisting of 16,080,000 shares of common stock (or pre-funded warrants in lieu thereof) and Series E warrants to purchase up to 48,240,000 shares of its common stock, at a combined public offering price per share of common stock (or per pre-funded warrant in ...
- Jonathan Moreland
PZG PARAMOUNT GOLD NEVADA CORP.
GIII G-III APPAREL GROUP LTD.
CIA CITIZENS INC. CL A
RSSS RESEARCH SOLUTIONS
BWB BRIDGEWATER BANCSHARES
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
WSC WILLSCOT MOBILE MINI HOLDINGS CORP
NUVB NUVATION BIO INC (A)
XLO XILIO THERAPEUTICS INC
EVM EATON VANCE INSD CALIF MUN BD FD
THOR Industries Announces Regular Quarterly Dividend
THOR Industries Announces Regular Quarterly Dividend ELKHART, Ind., June 18, 2025 (GLOBE NEWSWIRE) -- THOR Industries, Inc. (NYSE: THO) today announced that its Board of Directors approved, at its June 18, 2025, meeting, the payment of a regular quarterly cash dividend of $0.50 per share. The regular cash dividend is payable on July 15, 2025, to shareholders of record at the close of business on July 1, 2025. About THOR Industries, Inc. THOR is the sole owner of operating companies which, combined, represent the world's largest manufacturer of recreational vehicles. For more informati...
Moleculin Participates in Virtual Investor “What This Means” Segment
Moleculin Participates in Virtual Investor “What This Means” Segment HOUSTON, June 18, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced that it participated in a . As part of the segment, Walter Klemp, Founder, President, CEO and Chairman of Moleculin, discussed the Company’s recently announced positive FDA feedback received on the Pediatric Study Plan for Annamycin in children with relapsed/refractory ...
Moleculin Receives Positive FDA Feedback on Pediatric Study Plan for A...
Moleculin Receives Positive FDA Feedback on Pediatric Study Plan for Annamycin in Children with R/R AML Annamycin aims to eliminate cardiotoxicity associated with anthracyclines used to treat about 60% of all children with cancer FDA recommends inclusion of patients as young as 6 months – younger than Moleculin had proposed – to be allowed in the pediatric clinical study Enrollment and dosing are ongoing in pivotal, adaptive design Phase 3 MIRACLE trial of Annamycin in adult patients with R/R AML; Initial data readout is on track for the second half of 2025 HOUSTON, June 18, 2025 (GLO...
Immuneering Reports Positive Overall Survival Data for Atebimetinib (I...
Immuneering Reports Positive Overall Survival Data for Atebimetinib (IMM-1-104) from Ongoing Phase 2a Trial in First-Line Pancreatic Cancer Patients - 94% OS and 72% PFS observed at 6 months for atebimetinib (IMM-1-104) in combination with modified Gemcitabine/nab-paclitaxel (mGnP), N=34; median OS and PFS not yet reached - - Striking tumor reductions with 39% overall response rate and 81% disease control rate observed as of the data cutoff, including many patients with deepening, durable regressions and multiple examples of individual lesions rendered undetectable - - Markedly favora...
- Jonathan Moreland
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
GLP GLOBAL PARTNERS LP
CDXS CODEXIS
BUSE FIRST BUSEY CORPORATION
AMPH AMPHASTAR PHARMACEUTICALS INC
OXM OXFORD INDUSTRIES INC.
PLYA PLAYA HOTELS & RESORTS
BCBP BCB BANCORP INC.
BRT BRT APARTMENTS
STKL SUNOPTA
SONO INC.
ENX SONOS
GRNT EATON VANCE NEW YORK MUNICIPAL BOND FUND
TCBX GRANIT SKOPKE
TYRA THIRD COAST BANCSHARES INC
BARK TYRA BIOSCIENCES INC
OPAL ORIGINAL BARK CO
PRME OPAL FUELS INC
GTE PRIME MEDICINE INC
SDHC GRAN TIERRA ENERGY INC.
NCDL SMITH DOUGLAS HOMES CORP
EVM NUVEEN CHURCHILL DIRECT LENDING CORP
EATON VANCE INSD CALIF MUN BD FD
Immuneering to Provide Updates from Phase 2a Clinical Trial of IMM-1-1...
Immuneering to Provide Updates from Phase 2a Clinical Trial of IMM-1-104 in First-Line Pancreatic Cancer Patients on Tuesday, June 17, 2025 CAMBRIDGE, Mass., June 16, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company outpacing cancer to help patients outlive their disease, today announced that it will host a conference call and live webcast at 8:00 am ET on June 17, 2025. The company is excited to provide updates from its ongoing Phase 2a clinical trial of IMM-1-104 in first-line pancreatic cancer patients. The conference call will be webc...
- Jonathan Moreland
MTH MERITAGE HOMES CORPORATION
INUV INUVO INC
BHC BAUSCH HEALTH COMPANIES INC.
ETON ETON PHARMACEUTICALS
BLDR BUILDERS FIRSTSOURCE
AWRE INC.
DLHC AWARE INC.
HLMN DALEIGH HOLDINGS CORP
GECC HILLMAN SOLUTIONS CORP.
PRME GREAT ELM CAPITAL CORP
GTE PRIME MEDICINE INC
MNR GRAN TIERRA ENERGY INC.
EVM MACH NATURAL RESOURCES LP
EATON VANCE INSD CALIF MUN BD FD
Moleculin Participates in Virtual Investor “What This Means” Segment
Moleculin Participates in Virtual Investor “What This Means” Segment Globally recognized Oncology Key Opinion Leader, Brian Andrew Van Tine, MD, PhD, discusses the positive topline results from the U.S. Phase 1B/2 clinical trial evaluating Annamycin for the treatment of Soft Tissue Sarcoma Lung Metastases (MB-107) HOUSTON, June 11, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced that it participated in...
Moleculin Releases On-Demand KOL Webcast to Discuss Data from its Phas...
Moleculin Releases On-Demand KOL Webcast to Discuss Data from its Phase 1B/2 Study of Annamycin for the Treatment of Soft Tissue Sarcoma (STS) Lung Metastases (MB-107) HOUSTON, June 05, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viruses, today announced the release of its discussing the final data from its U.S. Phase 1B/2 clinical trial evaluating Annamycin as monotherapy for the treatment of soft tissue sarcoma lung met...
Moleculin Reports Positive Topline Efficacy Results from U.S. Phase 1B...
Moleculin Reports Positive Topline Efficacy Results from U.S. Phase 1B/2 Clinical Trial Evaluating Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases (MB-107) Annamycin delivering better performance 7th line than would be expected even in 2nd line for monotherapy Responders (Stable Disease or Partial Response) after 2 cycles of Annamycin showed improvement in OS and Progression Free Survival (“PFS”) Clinical Benefit Rate (“CBR”) was 59.4% (n=32), comprised of 18 subjects with stable disease and 1 subject with a partial response Potential to address 13,500 new incidents ...
THOR Industries Announces Third Quarter Fiscal 2025 Results
THOR Industries Announces Third Quarter Fiscal 2025 Results CONTINUED EXECUTION OF KEY STRATEGIES LEADS TO STRONG QUARTER AS INITIATIVES BEGIN TO SHOW EFFECTS Fiscal 2025 Third Quarter Highlights ($ in thousands, except for per share data)Three Months Ended April 30, Nine Months Ended April 30, 2025 2024 Change 2025 2024 ChangeNet Sales$2,894,816 $2,801,113 3.3% $7,055,707 $7,509,241 (6.0)%Gross Profit$443,119 $421,852 5.0% $969,758 $1,050,631 (7.7)%Gross Profit Margin % 15.3% 15.1% +20 bps 13.7% 14.0% (30) bpsNet Income Attributable t...
- Jonathan Moreland
TDOC TELADOC HEALTH INC.
VFF VILLAGE FARMS INTERNATIONAL IN
SWM SCHWEITZER-MAUDUIT INTERNATIONAL INC.
CCO CLEAR CHANNEL OUTDOOR HOLDINGS INC
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
VLA ARBOR METALS
DLHC DALEIGH HOLDINGS CORP
IMNM IMMUNOME
TSHA TAYSHA GENE THERAPIES
AFBI AFFINITY BANCSHARES
EVM INC.
SDHY EATON VANCE INSD CALIF MUN BD FD
PGIM SHORT DURATION HIGH YIELD OPPORTUNITIES FUND
- Jonathan Moreland
CTBI COMMUNITY TRUST BANCORP INC.
BUSE FIRST BUSEY CORPORATION
VFF VILLAGE FARMS INTERNATIONAL IN
SWM SCHWEITZER-MAUDUIT INTERNATIONAL INC.
CIA CITIZENS INC. CL A
GBLI GLOBAL INDEMNITY PLC
SVRA SAVARA
BRT BRT APARTMENTS
TDW TIDEWATER INC
AMPY AMPLIFY ENERGY
ADV ADVANTAGE SOLUTIONS INC (A)
SMMT SUMMIT THERAPEUTICS INC
BHRB BURKE & HERBERT BANK & TR/VA
DPG DUFF & PHELPS GLOBAL UTIL INCOME FD
GENK GEN RESTAURANT GROUP INC
NKGN NKGEN BIOTECH INC
SLS SELLAS LIFE SCIENCES GROUP INC
- Jonathan Moreland
TTSH TILE SHOP HOLDINGS INC.
TRS TRIMAS CORPORATION
TLYS TILLYS
PENN PENN NATIONAL GAMING INC.
PEB PEBBLEBROOK HOTEL TRUST
MCY MERCURY GENERAL CORPORATION
LTRX LANTRONIX INC.
JRVR JAMES RIVER GROUP HOLDINGS LTD
FLO FLOWERS FOODS INC.
BUSE FIRST BUSEY CORPORATION
VFF VILLAGE FARMS INTERNATIONAL IN
EXP EAGLE MATERIALS INC.
SWM SCHWEITZER-MAUDUIT INTERNATIONAL INC.
BDL FLANIGAN'S ENTERPRISES INC.
UIHC UNITED INSURANCE HOLDINGS CORP.
BXC BLUELINX HOLDINGS
HAIN THE HAIN CELESTIAL GROUP
GPMT INC.
NHF GRANITE POINT MORTGAGE TRUST INC.
BCBP NEXPOINT CREDIT STRATEGIES FUN
BRT BCB BANCORP INC.
PMTS BRT APARTMENTS
MPB CPI CARD GROUP
NWPP MID PENN BANCORP INC.
RFL NEW PEOPLES BANKSHARES INC.
KKR RAFAEL HOLDINGS CL B
REZI KKR & CO. INC.
LBSRD RESIDEO TECHNOLOGIES
XRX INC.
VLA LIBERTY STAR URANIUM & METALS
INNV XEROX HOLDINGS CORPORATION
ALIT ARBOR METALS
TCRX INNOVAGE HOLDING
UDMY ALIGHT
BHRB INC. / DELAWARE
OPAL FIRST EAGLE ALTERNATIVE CAPITAL BDC INC
PRME UDEMY INC
VFC BURKE & HERBERT BANK & TR/VA
UHG OPAL FUELS INC
HYLN PRIME MEDICINE INC
NCDL VF CORPORATION
PROP UNITED HOMES GROUP INC
FIP HYLIION HOLDINGS CORP.
TXO NUVEEN CHURCHILL DIRECT LENDING CORP
NEO PRAIRIE OPERATING CO.
JEQ FTAI INFRASTRUCTURE INC
MORNINGSTAR PARTNERS
L.P.
NEO CORPORATE PUBLIC COMPANY LIMITED
THE JAPAN EQUITY FUND
INC.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.